首页> 美国卫生研究院文献>BMC Musculoskeletal Disorders >The efficacy of adalimumab in psoriatic arthritis concomitant to overlapping primary biliary cholangitis and primary sclerosing cholangitis: a case report
【2h】

The efficacy of adalimumab in psoriatic arthritis concomitant to overlapping primary biliary cholangitis and primary sclerosing cholangitis: a case report

机译:阿达木单抗治疗银屑病关节炎并发原发性胆源性胆管炎和原发性硬化性胆管炎的病例报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundThe overlap syndrome of primary biliary cholangitis (formerly called primary biliary cirrhosis) and primary sclerosing cholangitis is an extremely rare condition that has never been described in association with other immune-mediated diseases, including psoriatic arthritis. While treatment with anti-Tumour Necrosis Factor-alpha (TNF-α) agents has proved to be effective in inflammatory arthropathies such as psoriatic arthritis, they have been employed in only a limited number of patients with autoimmune hepatitis, and their effectiveness is unclear.
机译:背景:原发性胆源性胆管炎(以前称为原发性胆汁性肝硬化)和原发性硬化性胆管炎的重叠综合征是一种极为罕见的疾病,从未与其他免疫介导的疾病(包括银屑病关节炎)相关联地描述过。虽然已证明抗肿瘤坏死因子-α(TNF-α)药物可有效治疗炎性关节炎,如银屑病关节炎,但仅在少数自身免疫性肝炎患者中使用过,其疗效尚不清楚。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号